Analysts Set ArcBest Co. (NASDAQ:ARCB) Target Price at $142.50

ArcBest Co. (NASDAQ:ARCB – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and nine have issued a buy recommendation on […]

Leave a Reply

Your email address will not be published.

Previous post Heathrow Faces £900 Million Business Rates Bombshell
Next post Evolent Health, Inc. (NYSE:EVH) Receives Consensus Rating of “Moderate Buy” from Brokerages